FDA backs Pfizer COVID-19 booster shots for people 65 and older, those at high risk

The FDA’s decision came as CDC vaccine advisors wrapped up the first day of a two-day meeting on COVID-19 booster shots.

Subscribe to WCVB on YouTube now for more: http://bit.ly/1e8lAMZ

Get more Boston news: http://www.wcvb.com
Like us: https://www.facebook.com/wcvb5
Follow us: https://twitter.com/WCVB
Instagram: https://www.instagram.com/wcvb5/